Beyond bispecific CD19/CD20 CAR T-cells, ongoing clinical trials explore sequential CD20 CAR-T after CD19 CAR-T infusion and combined infusion of CD19 and CD20-specific CAR-T cells for r/r B-ALL or DLBCL. The gene discussed is MS4A1; the disease is diffuse large B-cell lymphoma.